+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Acute Agitation and Aggression Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Pharmaceuticals , Psychotherapeutic Devices), By Drug Class (Antipsychotics , Benzodiazepines, Others), By Route of Administration (Oral , Parenteral , Inhalation/Intranasal), By Indication (Schizophrenia, Bipolar Disorder, Dementia & Alzheimer’s Disease, Substance-Related States, Autism Spectrum Disorder ), By End User (Hospitals & Emergency Departments, Psychiatric Care Facilities, Residential Treatment Centers, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Acute Agitation and Aggression Treatment Market size is forecast to increase from $3.21 Billion in 2026 to $4.26 Billion in 2034 at a CAGR of 3.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005397
Pages: 223 Pages

Acupuncture Needles Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Disposable Needles, Reusable/Non-Disposable Needles), By Material (Stainless Steel, Gold, Silver, Copper, Plastic/Other Materials), By Design (Manual Needles, Spring-Loaded Needles, Electro-Acupuncture Needles, Thin/Ultra-fine Needles, Coated ), By Distribution Channel (Specialty Retailers & Distributors, Direct-to-Practitioner, Hospital & Retail Pharmacies, Online Marketplaces), By End User (Hospitals, Specialty & Multidisciplinary Clinics, Home-Care Settings, Pain Management & Wellness Centers) Companies, and Country Forecast, 2021 to 2034

Global Acupuncture Needles Market size is forecast to increase from $281.59 Million in 2026 to $455.63 Million in 2034 at a CAGR of 6.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005396
Pages: 221 Pages

Acupuncture Market Size, Share and Growth Outlook, 2026: Analysis By Treatment Type (Traditional Chinese Medicine , Needle Acupuncture, Electroacupuncture, Moxibustion, Cupping Therapy, Laser Acupuncture, Acupressure, Dry Needling), By Application (Pain Management , Psychological Disorders , Gynecological Disorders, Neurological Disorders , Digestive Disorders, Sports Injuries), By Age Group (Adults, Geriatric, Children/Pediatrics), By End User (Hospitals, Specialty Clinics, Wellness & Rehabilitation Centers, Home Care Settings, Sports Clinics) Companies, and Country Forecast, 2021 to 2034

Global Acupuncture Market size is forecast to increase from $46.38 Billion in 2026 to $89.08 Billion in 2034 at a CAGR of 8.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005395
Pages: 217 Pages

Active Wheelchair Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Manual, Power / Electric Active Wheelchairs), By Material Type (Aluminum Alloys, Titanium, Carbon Fiber), By Indication (Spinal Cord Injury, Cerebral Palsy, Muscular Dystrophy & Multiple Sclerosis, Amputation & Neuropathy, Parkinson's & Alzheimer's Disease, Others), By End-User (Rehabilitation Centers, Hospitals & Clinics, Home Care & Personal Settings) Companies, and Country Forecast, 2021 to 2034

Global Active Wheelchair Market size is forecast to increase from $1.92 Billion in 2026 to $2.75 Billion in 2034 at a CAGR of 4.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005394
Pages: 218 Pages

Active Pharmaceutical Ingredient (API) Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Traditional / Small-Molecule APIs, Highly Potent APIs , Biologics & Biotech APIs, Peptide & Oligonucleotide-Based APIs, Antibody-Drug Conjugates ), By Synthesis Type (Synthetic / Chemical Synthesis, Biotech / Biological Synthesis ), By Drug Type (Innovative Drugs, Generic Drugs), By Phase (Clinical-Stage Development, Commercial-Stage Manufacturing), By Therapeutic Area (Oncology, Cardiovascular Diseases, Diabetes & Endocrinology, Central Nervous System , Hormonal & Endocrine Disorders, Infectious Diseases, Glaucoma & Ophthalmology) Companies, and Country Forecast, 2021 to 2034

Global Active Pharmaceutical Ingredient (API) Market size is forecast to increase from $198.02 Billion in 2026 to $377.52 Billion in 2034 at a CAGR of 8.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005393
Pages: 211 Pages

Active Pharmaceutical Ingredient (API) CDMO Market Size, Share and Growth Outlook, 2026: Analysis By Molecule Size & Type (Small Molecules, Large / Biologic Molecules, Highly Potent APIs (HPAPIs, Peptides & Oligonucleotides), By Type of Synthesis Process (Synthetic Chemical Synthesis, Biological Synthesis), By Development Phase (Pre-Clinical & Early Clinical Stages, Late Clinical Stage, Commercial Manufacturing), By Service Type (Process R&D & Route Scouting, Analytical & Regulatory Support, cGMP Scale-up and Manufacturing, Integrated End-to-End Services), By Therapeutic Area (Oncology, Cardiovascular & Metabolic Diseases, Immunology & Rare Diseases, Central Nervous System (CNS) & Neurology, Infectious Diseases & Anti-infectives), By Customer Type (Big Pharma, Mid-Sized Pharma & Emerging Biotech, Generic Drug Manufacturers) Companies, and Country Forecast, 2021 to 2034

Global Active Pharmaceutical Ingredient (API) CDMO Market size is forecast to increase from $99.72 Billion in 2026 to $196.67 Billion in 2034 at a CAGR of 8.86% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005392
Pages: 220 Pages

Active Implantable Medical Devices Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Implantable Cardiac Pacemakers, Implantable Cardioverter-Defibrillators , Ventricular Assist Devices , Neurostimulators, Implantable Hearing Devices, Implantable Drug-Infusion Pumps, Insertable ), By Technology (Conventional Implantable Devices, MRI-Compatible Implantable Devices, Leadless and Wireless Implants, Rechargeable and Bio-resorbable Power Systems), By Application (Cardiovascular Disorders, Neurological and Neuromuscular Disorders, Hearing Loss and Auditory Impairments, Chronic Pain Management, Endocrine and Metabolic Disorders), By End-User (Hospitals and Specialized Cardiac Centers, Ambulatory Surgery Centers , Specialty Clinics, Home-Care and Remote Monitoring Settings) Companies, and Country Forecast, 2021 to 2034

Global Active Implantable Medical Devices Market size is forecast to increase from $31.37 Billion in 2026 to $61.14 Billion in 2034 at a CAGR of 8.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005391
Pages: 213 Pages

Active and Intelligent Packaging in Pharmaceutical Market Size, Share and Growth Outlook, 2026: Analysis By Packaging Type (Active Packaging, Intelligent ), By Technology (Oxygen Scavengers, Moisture and Humidity Absorbers, Odor and Gas Absorbers, Antimicrobial Packaging, Radio Frequency Identification , QR Codes and Smart Labels, Time-Temperature Indicators ), By Material Type (Plastics and Polymers, Paper and Paperboard, Glass and Metals, Biopolymers and Sustainable Materials), By Drug Delivery Form (Oral Solid Dose, Liquid and Parenteral Formulations, Topical and Transdermal Patches, Biologics and Biosimilars) Companies, and Country Forecast, 2021 to 2034

Global Active and Intelligent Packaging in Pharmaceutical Market size is forecast to increase from $3.46 Billion in 2026 to $6.55 Billion in 2034 at a CAGR of 8.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005390
Pages: 229 Pages

AAV Contract Development and Manufacturing Organizations (CDMO) Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Process Development , Analytical Method Development & Quality Control, Clinical-Stage Manufacturing , Commercial-Stage Manufacturing, Fill-Finish Services), By Platform (Mammarian Cell Culture , Insect Cell Culture , Others), By Application (Neurological Disorders, Ophthalmic Diseases, Metabolic & Genetic Disorders, Hematological Diseases, Oncology), By End-User (Pharmaceutical Companies, Biotechnology Companies, Academic Medical Centers & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global AAV Contract Development and Manufacturing Organizations (CDMO) Market size is forecast to increase from $1.2 Billion in 2026 to $3.21 Billion in 2034 at a CAGR of 13.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005389
Pages: 218 Pages

Activated Clotting Time Testing Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (ACT Analyzers , Consumables ), By Test Range (High-Range ACT Tests, Low-Range ACT Tests), By Technology (Optical Detection Systems, Mechanical Detection Systems, Laser-Based Detection Systems, Fluorescence-Based Detection Systems), By Application (Cardiovascular and Vascular Surgery, Interventional Cardiology , Extracorporeal Membrane Oxygenation , Hemodialysis, Critical Care and Emergency Medicine), By End-User (Hospitals and Operating Rooms, Ambulatory Surgical Centers , Clinical and Diagnostic Laboratories, Academic and Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Activated Clotting Time Testing Market size is forecast to increase from $1.48 Billion in 2026 to $2.62 Billion in 2034 at a CAGR of 7.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005388
Pages: 226 Pages